89bio (ETNB)
US Market

89bio (ETNB) Financial Statements


89bio Financial Overview

89bio's market cap is currently ―. The company's EPS TTM is $-3.539; its P/E ratio is -4.72; 89bio is scheduled to report earnings on May 10, 2023, and the estimated EPS forecast is $-0.55. See an overview of income statement, balance sheet, and cash flow financials.
Dec 22Sep 22Jun 22Mar 22Dec 21
Income Statement-
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit-----
EBIT$ -23.20M$ -27.04M$ -24.74M$ -25.11M$ -26.24M
EBITDA$ -23.18M$ -27.02M$ -24.72M$ -25.09M$ -26.22M
Net Income Common Stockholders$ -24.60M$ -26.80M$ -25.05M$ -25.57M$ -26.29M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 188.16M$ 193.34M$ 139.32M$ 126.09M$ 150.72M
Total Assets$ 196.82M$ 200.58M$ 147.59M$ 135.76M$ 162.42M
Total Debt$ 20.05M$ 20.02M$ 19.65M$ 19.47M$ 19.40M
Net Debt$ -168.12M$ -173.32M$ -119.67M$ -106.61M$ -131.32M
Total Liabilities$ 44.99M$ 48.01M$ 67.41M$ 33.02M$ 36.47M
Stockholders Equity$ 151.83M$ 152.57M$ 80.19M$ 102.74M$ 125.96M
Cash Flow-
Free Cash Flow$ -27.10M$ -14.81M$ -14.83M$ -24.35M$ -28.27M
Operating Cash Flow$ -27.10M$ -14.81M$ -14.84M$ -24.34M$ -28.24M
Investing Cash Flow$ -11.06M$ -42.06M$ -7.60M$ 26.77M$ 19.09M
Financing Cash Flow$ 21.01M$ 68.63M$ 28.16M$ 29.00K$ 21.89M
Currency in USD

89bio Earnings and Revenue History

89bio Debt to Assets

89bio Cash Flow

89bio Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis